OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
Michele Guida, Stefania Tommasi, Sabino Strippoli, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Michele Guida, Stefania Tommasi, Sabino Strippoli, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
Simona Serratì, Michele Guida, R. Fonte, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 109
Simona Serratì, Michele Guida, R. Fonte, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 109
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
Raúl Ortíz, Gloria Perazzoli, Laura Cabeza, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 513-537
Open Access | Times Cited: 108
Raúl Ortíz, Gloria Perazzoli, Laura Cabeza, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 513-537
Open Access | Times Cited: 108
Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons
Matilde Clarissa Malfatti, Alessia Bellina, Giulia Antoniali, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1895-1895
Open Access | Times Cited: 24
Matilde Clarissa Malfatti, Alessia Bellina, Giulia Antoniali, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1895-1895
Open Access | Times Cited: 24
Protocatechuic aldehyde sensitizes BRAF-mutant melanoma cells to temozolomide through inducing FANCD2 degradation
Jie Yang, Xin Zeng, Junxia Pei, et al.
Medical Oncology (2025) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
Jie Yang, Xin Zeng, Junxia Pei, et al.
Medical Oncology (2025) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
Mingming Song, Chang Liu, Siyu Chen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1873-1873
Open Access | Times Cited: 51
Mingming Song, Chang Liu, Siyu Chen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1873-1873
Open Access | Times Cited: 51
Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma
Siddhartha Sood, Rahul Jayachandiran, Siyaram Pandey
Integrative Cancer Therapies (2021) Vol. 20
Open Access | Times Cited: 38
Siddhartha Sood, Rahul Jayachandiran, Siyaram Pandey
Integrative Cancer Therapies (2021) Vol. 20
Open Access | Times Cited: 38
Decoding the Role of CD271 in Melanoma
Anna Vidal, Torben Redmer
Cancers (2020) Vol. 12, Iss. 9, pp. 2460-2460
Open Access | Times Cited: 24
Anna Vidal, Torben Redmer
Cancers (2020) Vol. 12, Iss. 9, pp. 2460-2460
Open Access | Times Cited: 24
Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer
Filippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.
Cancer Treatment Reviews (2019) Vol. 82, pp. 101935-101935
Closed Access | Times Cited: 22
Filippo Pietrantonio, Giovanni Randon, Dario Romagnoli, et al.
Cancer Treatment Reviews (2019) Vol. 82, pp. 101935-101935
Closed Access | Times Cited: 22
Burden and Risk Factors of Brain Metastases in Melanoma: A Systematic Literature Review
Xiang‐Lin Tan, Amy Le, Huilin Tang, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6108-6108
Open Access | Times Cited: 10
Xiang‐Lin Tan, Amy Le, Huilin Tang, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6108-6108
Open Access | Times Cited: 10
Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons
Matilde Clarissa Malfatti, Alessia Bellina, Giulia Antoniali, et al.
(2023)
Open Access | Times Cited: 6
Matilde Clarissa Malfatti, Alessia Bellina, Giulia Antoniali, et al.
(2023)
Open Access | Times Cited: 6
DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide
Marcela Teatin Latância, Natália Cestari Moreno, Giovana da Silva Leandro, et al.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2022) Vol. 878, pp. 503498-503498
Open Access | Times Cited: 9
Marcela Teatin Latância, Natália Cestari Moreno, Giovana da Silva Leandro, et al.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2022) Vol. 878, pp. 503498-503498
Open Access | Times Cited: 9
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
Raúl Ortíz
Current Neuropharmacology (2021) Vol. 19, Iss. 4, pp. 513-537
Open Access | Times Cited: 11
Raúl Ortíz
Current Neuropharmacology (2021) Vol. 19, Iss. 4, pp. 513-537
Open Access | Times Cited: 11
Protocatechuic aldehyde acts synergistically with dacarbazine to augment DNA double-strand breaks and promote apoptosis in cutaneous melanoma cells
Junxia Pei, Su Zhou, Xin Zeng, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Junxia Pei, Su Zhou, Xin Zeng, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Exploring the Multifaceted Effects of Silymarin on Melanoma: Focusing on the Role of Lipid-Based Nanocarriers
Faezeh Arghidash, Mohammad Javad Javid‐Naderi, Fatemeh Gheybi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105950-105950
Closed Access | Times Cited: 1
Faezeh Arghidash, Mohammad Javad Javid‐Naderi, Fatemeh Gheybi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105950-105950
Closed Access | Times Cited: 1
Synthesis of novel α-aminophosphonates under microwave irradiation, biological evaluation as antiproliferative agents and apoptosis inducers
Erika L. Loredo-Calderón, Carlos A. Velázquez‐Martínez, Mónica A. Ramírez‐Cabrera, et al.
Medicinal Chemistry Research (2019) Vol. 28, Iss. 11, pp. 2067-2078
Closed Access | Times Cited: 8
Erika L. Loredo-Calderón, Carlos A. Velázquez‐Martínez, Mónica A. Ramírez‐Cabrera, et al.
Medicinal Chemistry Research (2019) Vol. 28, Iss. 11, pp. 2067-2078
Closed Access | Times Cited: 8
The evolving landscape in the management of gastric metastases from melanoma: a case series
Sabino Strippoli, Eustachio Ruggeri, Livia Fucci, et al.
Clinical Practice (2019) Vol. 16, Iss. 2
Open Access | Times Cited: 3
Sabino Strippoli, Eustachio Ruggeri, Livia Fucci, et al.
Clinical Practice (2019) Vol. 16, Iss. 2
Open Access | Times Cited: 3
Progress in the Treatment of Advanced Melanoma
艳琳 谢
Advances in Clinical Medicine (2022) Vol. 12, Iss. 06, pp. 5256-5262
Closed Access
艳琳 谢
Advances in Clinical Medicine (2022) Vol. 12, Iss. 06, pp. 5256-5262
Closed Access
Immunological Features of Melanoma: Clinical Implications in the Era of New Therapies
Licia Rivoltini, Agata Cova, Paola Squarcina
Springer eBooks (2021), pp. 99-128
Closed Access
Licia Rivoltini, Agata Cova, Paola Squarcina
Springer eBooks (2021), pp. 99-128
Closed Access
